ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease.
about
The critical role of the central nervous system (pro)renin receptor in regulating systemic blood pressureTreating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola.Angiotensin-(1-7) reverses angiogenic dysfunction in corpus cavernosum by acting on the microvasculature and bone marrow-derived cells in diabetesStabilization of the angiotensin-(1-7) receptor Mas through interaction with PSD95.Protective Role of the ACE2/Ang-(1-9) Axis in Cardiovascular Remodeling.Soluble thrombomodulin reduces inflammation and prevents microalbuminuria induced by chronic endothelial activation in transgenic miceAngiotensin 1-7 Protects against Angiotensin II-Induced Endoplasmic Reticulum Stress and Endothelial Dysfunction via Mas ReceptorGenetic Deletion of ACE2 Induces Vascular Dysfunction in C57BL/6 Mice: Role of Nitric Oxide Imbalance and Oxidative StressAngiotensin-(1-7) administration benefits cardiac, renal and progenitor cell function in db/db mice.Aliskiren effect on plaque progression in established atherosclerosis using high resolution 3D MRI (ALPINE): a double-blind placebo-controlled trial.Effects of rosuvastatin on expression of angiotensin-converting enzyme 2 after vascular balloon injury in rats.Angiotensin-converting enzyme 2 activation improves endothelial functionAngiotensin-(1-7) inhibits inflammation and oxidative stress to relieve lung injury induced by chronic intermittent hypoxia in ratsCD36/Sirtuin 1 Axis Impairment Contributes to Hepatic Steatosis in ACE2-Deficient Mice.New cardiovascular and pulmonary therapeutic strategies based on the Angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor axis.Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin-angiotensin system: a patent review.The renin-angiotensin system, bone marrow and progenitor cells.Opportunities for targeting the angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor pathway in hypertension.Angiotensin-(1-7): beyond the cardio-renal actions.Pathophysiological role of the renin-angiotensin system on erectile dysfunction.Investigational drugs targeting cardiac fibrosis.Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets.Angiotensin II type II receptor deficiency accelerates the development of nephropathy in type I diabetes via oxidative stress and ACE2.Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive ratsOlmesartan improves endothelial function in hypertensive patients: link with extracellular superoxide dismutase.ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke.The role of epidermal growth factor receptor in diabetes-induced cardiac dysfunction.Serum angiotensin-converting enzyme 2 concentration and angiotensin-(1-7) concentration in patients with acute heart failure patients requiring emergency hospitalization.Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2- and NF-κB-dependent pathways.Angiotensin-(1-7) counteracts the transforming effects triggered by angiotensin II in breast cancer cells.Prolonged treatment with angiotensin 1-7 improves endothelial function in diet-induced obesity.Angiotensin-(1-7)-mediated Mas1 receptor/NF-κB-p65 signaling is involved in a cigarette smoke-induced chronic obstructive pulmonary disease mouse model.Angiotensin-(1-7) Inhibits Thrombin-Induced Endothelial Phenotypic Changes and Reactive Oxygen Species Production via NADPH Oxidase 5 Downregulation.Evaluation of Endothelial Dysfunction In Vivo.
P2860
Q26750465-6282407D-0F6D-4D38-86C1-B113D224C93CQ28076034-69D0E726-9FB3-41D5-896B-F011FA247828Q34111573-B88529A1-B171-4557-8E72-E9689CDBAB28Q34735823-A6C0B17B-4271-40DD-AC57-A00D667B7834Q35726197-B71D5DFE-B539-48A7-9166-D41B5CDA6E52Q35849496-D64FAEA6-2F4A-4BB3-B3D3-C6F412DCB0F7Q35879328-851B4639-D27F-4427-9B22-BEF1DFD12151Q35986974-FA5926F7-20EF-409C-B54C-8903654CC7DDQ36036207-53DA90E3-F9A1-47FC-8C7D-5C223539A4C5Q36974370-973E7E7D-DDFA-452B-9681-42A84B59D046Q37001571-4DD91AA3-91AE-40E0-96D0-84432C4DEA5CQ37069541-B9AB2D15-E9CF-4E4A-BC6E-4DA4A736165FQ37247339-E5AB20F1-B900-4D08-9607-AF585455C7BEQ37560592-138FE4AC-3337-4A18-B4A1-AF8D9AE5E0C3Q37982718-BBAE9618-E614-402E-9D08-B79A4D0510DAQ38003191-1E9984FE-99FC-4C1A-A5BF-060E829EFE38Q38006725-84128FD7-2E43-40BB-90CC-CD8476EBD836Q38065112-AD038ADC-6150-47E9-8D5D-B429525F173CQ38068237-080636C6-51AE-43C6-9191-ADB43A2B2180Q38126111-C4E57C1D-A1A9-4DFE-BB54-E69DB00427EDQ38161896-6DC77831-7A68-42F7-95C6-40885A34CF01Q38207841-2552C12E-F3A5-4C72-9167-2E99117A8D6FQ38895396-FCE381A2-CB27-4A77-B162-086F87CCBD0BQ39660661-A7E17C0F-BE2D-4F9A-9377-DC90F02F6930Q39784603-2C444844-A42F-4635-9ABA-48B3602293BEQ40159156-B0B5C7D0-6663-4734-81FA-706AE4D9849DQ40552347-25922A3F-F82F-49AF-AD24-6348C8C52F53Q41943681-05116898-4877-4F39-9500-F04EBEBCBF41Q42246428-32F0945B-498A-4C19-8272-4AFCE8BB1EA9Q44861712-B3375869-96C3-432B-9DE8-B3671F0424FEQ46205392-8E317891-291C-4800-987F-4112DCE1413BQ47726786-C06A2213-A970-446F-B824-25C766B0F5FAQ49631904-913F0C73-AE6C-4347-8E07-D372F258B0D4Q52842265-D2BBE257-9163-40C4-85AE-91985E579C3A
P2860
ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
ACE2-angiotensin-
@nl
ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease.
@en
type
label
ACE2-angiotensin-
@nl
ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease.
@en
prefLabel
ACE2-angiotensin-
@nl
ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease.
@en
P2860
P356
P1476
ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease.
@en
P2093
Luiza A Rabelo
Natalia Alenina
P2860
P2888
P304
P356
10.1038/HR.2010.235
P577
2010-12-02T00:00:00Z
P6179
1001239923